HHV-8, angiogenesis and inflammation

HHV-8、血管生成和炎症

• 批准号: 8337885
• 负责人: Bala Chandran
• 金额: $ 38.63万
• 依托单位: ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-30 至 2013-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8337885
• 关键词: Address; Angiogenic Factor; Angiopoietins; Antibodies; Apoptosis; Apoptotic; B-Cell Lymphomas; Basement membrane; Biological; Biology; Blood Vessels; Blood capillaries; Cell Cycle; Cell Nucleolus; Cell Nucleus; Cell Proliferation; Cells; Chronic; Complex; DNA Binding; Dermal; Development; Dinoprostone; Disease; Endothelial Cells; Event; Extracellular Matrix Degradation; Fibroblast Growth Factor 2; Gene Expression; Generations; Genes; Genetic Transcription; Growth Factor; Healed; Herpesviridae; Human; Human Herpesvirus 8; Hyperplasia; Infection; Inflammation; Inflammatory; Inflammatory Response; Integration Host Factors; Kaposi Sarcoma; Knowledge; Lead; Lesion; Link; Lymphoma; Lymphoproliferative Disorders; Lytic; Malignant Neoplasms; Mediating; Mediator of activation protein; Microarray Analysis; Microbe; Modeling; Molecular; Neomycin; Nuclear; Nuclear Translocation; Open Reading Frames; PTGS2 gene; Plasmin; Play; Process; Protein p53; Proteins; Proteomics; Regulation; Resolution; Role; Sexually Transmitted Agents; Shapes; Stimulus; Suspension substance; Suspensions; Testing; Therapeutic; Therapeutic Agents; Tissues; Tube; Vascular Endothelial Growth Factors; Viral; angiogenesis; angiogenin; capillary; cytokine; effusion; healing; in vivo; inhibitor/antagonist; latency-associated nuclear antigen; latent infection; migration; neovascular; new therapeutic target; novel; novel therapeutics; rRNA Genes; response; ribosomal protein L11; tumorigenesis